ATE284900T1 - Spezifische antikörper für dendritische zellen - Google Patents

Spezifische antikörper für dendritische zellen

Info

Publication number
ATE284900T1
ATE284900T1 AT97945110T AT97945110T ATE284900T1 AT E284900 T1 ATE284900 T1 AT E284900T1 AT 97945110 T AT97945110 T AT 97945110T AT 97945110 T AT97945110 T AT 97945110T AT E284900 T1 ATE284900 T1 AT E284900T1
Authority
AT
Austria
Prior art keywords
dendritic cells
specific antibodies
antigen
antibody
antibodies
Prior art date
Application number
AT97945110T
Other languages
English (en)
Inventor
Derek Nigel John Hart
Original Assignee
Canterbury Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canterbury Health Ltd filed Critical Canterbury Health Ltd
Application granted granted Critical
Publication of ATE284900T1 publication Critical patent/ATE284900T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97945110T 1996-10-09 1997-10-09 Spezifische antikörper für dendritische zellen ATE284900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ29953796 1996-10-09
PCT/NZ1997/000134 WO1998015579A1 (en) 1996-10-09 1997-10-09 Dendritic cell-specific antibodies

Publications (1)

Publication Number Publication Date
ATE284900T1 true ATE284900T1 (de) 2005-01-15

Family

ID=19925969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945110T ATE284900T1 (de) 1996-10-09 1997-10-09 Spezifische antikörper für dendritische zellen

Country Status (7)

Country Link
US (1) US6479247B1 (de)
EP (1) EP0956304B1 (de)
JP (2) JP2001502670A (de)
AT (1) ATE284900T1 (de)
AU (1) AU744637B2 (de)
DE (1) DE69731977T2 (de)
WO (1) WO1998015579A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258688A1 (en) * 1995-01-31 2004-12-23 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
US20020187131A1 (en) * 1995-01-31 2002-12-12 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
WO1999006811A2 (en) * 1997-08-01 1999-02-11 Derek Nigel John Hart Method for counting dendritic cells
EP1078060B1 (de) * 1998-05-11 2007-01-10 E.P. Prof. Dr. Rieber Antikörper gegen dendritische zellen und menschliche dendritische zellpopulationen und deren verwendungen
US6495333B1 (en) 1998-09-22 2002-12-17 Becton Dickinson And Company Flow cytometric, whole blood dendritic cell immune function assay
US7351546B2 (en) 1998-09-22 2008-04-01 Becton, Dickinson And Company Flow cytometric, whole blood dendritic cell immune function assay
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
WO2001040308A1 (en) * 1999-12-03 2001-06-07 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Dendritic cell-specific antibodies
ATE553131T1 (de) * 2000-05-08 2012-04-15 Celldex Res Corp Humane monoklonale antikörper gegen dendritische zellen
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
EP1594533B1 (de) 2003-01-31 2012-04-11 Celldex Research Corporation Antikörper-vakzine-konjugate und ihre verwendungen
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
JP5160412B2 (ja) * 2006-04-13 2013-03-13 株式会社医学生物学研究所 融合パートナー細胞
KR101811965B1 (ko) 2007-11-07 2017-12-22 셀덱스 쎄라퓨틱스, 인크. 인간 수지상 및 상피 세포 205(ｄｅｃ-205)에 결합하는 항체
PT3903829T (pt) 2009-02-13 2023-06-02 Immunomedics Inc Imunoconjugados com uma ligação intracelular clivável
WO2011034660A1 (en) 2009-09-16 2011-03-24 Immunomedics, Inc. Class i anti-cea antibodies and uses thereof
ES2978177T3 (es) 2009-12-02 2024-09-06 Immunomedics Inc Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
EP2550893A1 (de) 2011-07-23 2013-01-30 Braun GmbH Oraler Reinigungseinsatz mit einer Kunststoffklammer mit einem Hohlraum
AU2013302696B9 (en) 2012-08-14 2018-08-09 Ibc Pharmaceuticals, Inc. T-cell redirecting bispecific antibodies for treatment of disease
CA3177936A1 (en) 2012-12-13 2014-06-19 Immunomedics, Inc. Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
WO2015126548A1 (en) 2014-02-21 2015-08-27 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to trop-2 expressing cells
CN106029098A (zh) 2014-02-25 2016-10-12 免疫医疗公司 人源化rfb4抗cd22抗体
US9580495B2 (en) 2014-06-24 2017-02-28 Immunomedics, Inc. Anti-histone therapy for vascular necrosis in severe glomerulonephritis
SI3204018T1 (sl) 2014-10-07 2021-11-30 Immunomedics, Inc. Neoadjuvantna uporaba konjugatov protitelo-zdravilo
CN109320610B (zh) * 2015-01-27 2021-07-27 中国科学技术大学先进技术研究院 抗人cd83单克隆抗体及其制备、鉴定和应用
WO2016172427A1 (en) 2015-04-22 2016-10-27 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
EP3313443B9 (de) 2015-06-25 2023-10-04 Immunomedics, Inc. Kombination von anti-hla-dr- oder anti-trop-2-antikörpern mit mikrotubuli-inhibitoren, parp-inhibitoren, bruton-kinase-inhibitoren oder phosphoinositol-3-kinase-inhibitoren zur signifikanten verbesserung des therapeutischen ergebnisses bei krebs
SI3316885T1 (sl) 2015-07-01 2021-09-30 Immunomedics, Inc. Imunokonjugati protitelo-SN-38 z linkerjem CL2A
WO2022239720A1 (ja) 2021-05-10 2022-11-17 公益財団法人川崎市産業振興財団 抗原への結合親和性を低減させた抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
AU8068694A (en) 1993-11-04 1995-05-23 Canterbury Health Limited Dendritic cell-specific antibodies and methods for their preparation
WO1995015340A1 (en) * 1993-12-03 1995-06-08 The Board Of Trustees Of Leland Stanford Junior University Monoclonal antibodies to antigens expressed by human dendritic cells

Also Published As

Publication number Publication date
EP0956304A4 (de) 2000-01-26
EP0956304B1 (de) 2004-12-15
WO1998015579A1 (en) 1998-04-16
DE69731977D1 (de) 2005-01-20
DE69731977T2 (de) 2005-12-08
AU4639397A (en) 1998-05-05
JP2008148707A (ja) 2008-07-03
EP0956304A1 (de) 1999-11-17
US20020155510A1 (en) 2002-10-24
AU744637B2 (en) 2002-02-28
US6479247B1 (en) 2002-11-12
JP2001502670A (ja) 2001-02-27

Similar Documents

Publication Publication Date Title
DE69731977D1 (de) Spezifische antikörper für dendritische zellen
SE9502196D0 (sv) Ultrasensitive immunoassays
AU2555297A (en) Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
AR008919A1 (es) Anticuerpos anti-cd11a humanizados.
CA2198958A1 (en) Method for amplification of the response signal in a sandwich immunoassay
DK1233987T3 (da) Immobiliserede enkelt-domæne antigenbindende molekyler
NZ330475A (en) Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation
FI971883A0 (fi) Vasta-aineluokkapesifinen häiriöitä estävä reagenssi
EP0352722A3 (de) Bindungstests für Adenocarcinoma-Antigen und Reagenzien
BR0011449A (pt) Método para detectar sìfilis usando antìgenos sintéticos
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
EP0824104A3 (de) Immunotestverfahren
CA2213083A1 (en) Detection of antibody production
AU4086397A (en) Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
ES2187639T3 (es) Analisis de fijacion competitiva para antigenos plaquetarios.
Hajdu The immunohistochemical detection of J chain in lymphoid cells in tissue sections: the necessity of trypsin digestion
DE69526056D1 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties